Steve Gamblin

InstitutionFrancis Crick Institute
AddressLondon
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 16 Covid-19 publications, with a maximum of 4 publications in October 2020
    All Publications
    Bar chart showing 63 publications over 18 distinct years, with a maximum of 10 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Deakin CT, Cornish GH, Ng KW, Faulkner N, Bolland W, Hope J, Rosa A, Harvey R, Hussain S, Earl C, Jebson BR, Wilkinson MGLL, Marshall LR, O'Brien K, Rosser EC, Radziszewska A, Peckham H, Patel H, Heaney J, Rickman H, Paraskevopoulou S, Houlihan CF, Spyer MJ, Gamblin SJ, McCauley J, Nastouli E, Levin M, Cherepanov P, Ciurtin C, Wedderburn LR, Kassiotis G. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. Med (N Y). 2021 Sep 10; 2(9):1093-1109.e6. PMID: 34414384.
      Citations:    
    2. Faulkner N, Ng KW, Wu MY, Harvey R, Margaritis M, Paraskevopoulou S, Houlihan C, Hussain S, Greco M, Bolland W, Warchal S, Heaney J, Rickman H, Spyer M, Frampton D, Byott M, de Oliveira T, Sigal A, Kjaer S, Swanton C, Gandhi S, Beale R, Gamblin SJ, McCauley JW, Daniels RS, Howell M, Bauer D, Nastouli E, Kassiotis G. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains. Elife. 2021 07 29; 10. PMID: 34323691.
      Citations: 12     Fields:    Translation:Humans
    3. Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Adams L, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 07 17; 398(10296):207-209. PMID: 34197809.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    4. Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Nicod J, Goldstone R, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 06 19; 397(10292):2331-2333. PMID: 34090624.
      Citations: 93     Fields:    Translation:Humans
    5. Benton DJ, Wrobel AG, Roustan C, Borg A, Xu P, Martin SR, Rosenthal PB, Skehel JJ, Gamblin SJ. The effect of the D614G substitution on the structure of the spike glycoprotein of SARS-CoV-2. Proc Natl Acad Sci U S A. 2021 03 02; 118(9). PMID: 33579792.
      Citations: 23     Fields:    Translation:HumansCells
    6. Wrobel AG, Benton DJ, Xu P, Calder LJ, Borg A, Roustan C, Martin SR, Rosenthal PB, Skehel JJ, Gamblin SJ. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2. Nat Commun. 2021 02 05; 12(1):837. PMID: 33547281.
      Citations: 11     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Citations: 239     Fields:    Translation:HumansAnimalsCells
    8. Black JRM, Bailey C, Przewrocka J, Dijkstra KK, Gandhi S, Gamblin S, Barrell S, Swanton C. Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK - Authors' reply. Lancet. 2020 10 24; 396(10259):1329-1330. PMID: 34338203.
      Citations:    Fields:    Translation:Humans
    9. Wrobel AG, Benton DJ, Hussain S, Harvey R, Martin SR, Roustan C, Rosenthal PB, Skehel JJ, Gamblin SJ. Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein. Nat Commun. 2020 10 21; 11(1):5337. PMID: 33087721.
      Citations: 9     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Ng KW, Attig J, Bolland W, Young GR, Major J, Wrobel AG, Gamblin S, Wack A, Kassiotis G. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option. Nat Genet. 2020 12; 52(12):1294-1302. PMID: 33077915.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    11. Wrobel AG, Benton DJ, Xu P, Roustan C, Martin SR, Rosenthal PB, Skehel JJ, Gamblin SJ. Author Correction: SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat Struct Mol Biol. 2020 Oct; 27(10):1001. PMID: 32848232.
      Citations: 6     Fields:    
    12. Benton DJ, Wrobel AG, Xu P, Roustan C, Martin SR, Rosenthal PB, Skehel JJ, Gamblin SJ. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature. 2020 12; 588(7837):327-330. PMID: 32942285.
      Citations: 127     Fields:    Translation:HumansCells
    13. Citations: 1     Fields:    
    14. Citations: 11     Fields:    Translation:Humans
    15. Wrobel AG, Benton DJ, Xu P, Roustan C, Martin SR, Rosenthal PB, Skehel JJ, Gamblin SJ. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Nat Struct Mol Biol. 2020 08; 27(8):763-767. PMID: 32647346.
      Citations: 128     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    16. Houlihan CF, Vora N, Byrne T, Lewer D, Kelly G, Heaney J, Gandhi S, Spyer MJ, Beale R, Cherepanov P, Moore D, Gilson R, Gamblin S, Kassiotis G, McCoy LE, Swanton C, Hayward A, Nastouli E. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020 07 25; 396(10246):e6-e7. PMID: 32653078.
      Citations: 65     Fields:    Translation:HumansCellsPHPublic Health
    Gamblin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (114)
    Explore
    _
    Co-Authors (163)
    Explore
    _
    Similar People (60)
    Explore
    _